News • 15-6-2016

Lower blood sugar with DPP-4 inhibitor in adults with type 2 diabetes at risk for renal impairment

ADA 2016 In 360 patients with T2DM and albuminuria, linagliptin significantly reduced blood glucose levels, is well tolerated and does not need dose adjustment in patients at risk for kidney impairment. Read more
News • 15-6-2016

All age groups have CV benefit from SGLT2 inhibition in type 2 diabetes

ADA 2016 New empagliflozin data show that reduced risk for cardiovascular death was consistent across age groups in adults with type 2 diabetes. Read more

Cardiac function and structure improved by vitamin D supplementation in heart failure patients

9-6-2016 • Witte KK, et al. J Am Coll Cardiol 2016
In patients with chronic HF and vitamin D deficiency, high-dose vitamin D3 supplementation is safe, well tolerated, and associated with a favourable effect on cardiac function and structure. Read more

Lower-risk AF patients also benefit from oral anticoagulation, new data show

9-6-2016 • Fauchier L et al., Stroke. 2016
Among AF patients with only 1 nongender-related stroke risk factor, OAC was associated with a positive net clinical benefit for the prevention of stroke and thromboembolic events. Read more

Common side effects observed with statin therapy

2-6-2016 • Thomson PD et al., JACC 2016
Statin-associated muscle symptoms, diabetes mellitus and central nervous system complaints are often seen with statin therapy. This review gives an overview. Read more
News • 30-5-2016

European guidelines on CVD prevention reaffirm LDL-c as the priority for lipid control

EAS 2016 Guidelines on cardiovascular disease prevention from the Sixth Joint Task Force provide up-to-date accessible recommendations for lipid control for clinicians in their routine practice. Read more
News • 15-6-2016

Highest CV mortality risk for T2DM patients previously hospitalised with heart failure

ADA 2016 Evaluation CV mortality risk for 5380 EXAMINE patients with T2DM on alogliptin/placebo, showed that risk for patients experiencing a non-fatal CV was especially increased for HHF patients. Read more

Higher risk of hypertension associated with exposure to air pollutants

10-6-2016 • Cai Y et al., Hypertension. 2016
In a systematic review and meta-analysis of 17 studies, the short-term and long-term exposure to air pollutants was significantly associated with increased risk for hypertension. Read more

Direct oral anticoagulants result in lower risk of dementia in atrial fibrillation patients

9-6-2016 • Jacobs V, et al. Am J Cardiol. 2016
Treatment with direct oral anticoagulants was associated with a lower risk of cerebral ischemic events and new-onset dementia, in a retrospective analysis of 5,254 patients with atrial fibrillation. Read more

Type 2 diabetic patients significantly benefit from light exercises

7-6-2016 • Dempsey PC et al., Diabetes Care 2016
Sitting interrupted by light-intensity walking or simple resistance activities contributes to better postprandial metabolic levels in T2D patients and may reduce the risk for complications. Read more

Lower absolute number of bleeding events in the elderly with NOAC than with warfarin

1-6-2016 • Kato S et al., J Am Heart Assoc. 2016
In a pre-specified analysis from the ENGAGE AF-TIMI 48 trial, given the higher rates of bleeding in the elderly, a greater absolute reduction in safety events was seen with edoxaban as compared with warfarin than in younger patients. Read more
E-Learning •

The evidence base for health behaviour changes

Prof. Richard Hobbs (Oxford, UK)  and Prof. Paul Aveyard (Oxford, UK) discuss the evidence base of effectiveness of health behaviour changes and how GPs can best play a role in stimulating a patient to engage in lifestyle modifications to reduce their CV risk.  Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...